T1	Participants 233 272	heart- and kidney-transplant recipients
T2	Participants 476 504	heart-transplant recipients.
T3	Participants 513 604	Twenty heart-transplant recipients were randomised into either a treated or a placebo group
T4	Participants 1227 1356	one patient in the ticlopidine group was withdrawn because of a major fall in cyclosporin blood level within 3 days of treatment.
T5	Participants 1438 1487	ticlopidine group compared with the placebo group
T6	Participants 1817 1887	patient withdrawn from this study and in previous uncontrolled studies
